Genetic proxies for therapy of insulin drug targets and risk of osteoarthritis: a drug-target Mendelian randomization analysis.
Ziqin CaoQiangxiang LiJian-Huang WuYajia LiPublished in: Inflammopharmacology (2024)
There was a causal association between genetically proxied insulin therapy and a higher risk of OA, especially HOA.